Daewoong Pharmaceutical Co., Ltd (KRX:069620)

Daewoong Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,943,409	1,454,393	1,343,932	1,754,469	1,638,243	1,775,845
Market Cap Growth	32.78%	8.22%	-23.40%	7.09%	-7.75%	25.14%
Enterprise Value	2,687,142	2,099,040	1,735,899	2,148,696	2,022,062	2,205,804
Last Close Price	168900.00	125964.64	115832.21	156366.58	145448.14	161495.41
PE Ratio	20.86	58.80	11.04	41.54	66.85	139.25
Forward PE	11.57	14.39	14.77	22.77	41.35	41.35
PS Ratio	1.26	1.02	0.98	1.37	1.42	1.68
PB Ratio	1.87	1.51	1.43	2.37	2.35	2.55
P/TBV Ratio	3.82	2.24	2.15	3.79	3.83	4.26
P/FCF Ratio	-	-	50.39	33.11	150.21	23.84
P/OCF Ratio	14.79	28.25	9.88	14.84	40.96	17.59
PEG Ratio	0.19	0.24	0.24	0.24	0.24	0.24
EV/Sales Ratio	1.74	1.48	1.26	1.68	1.75	2.09
EV/EBITDA Ratio	13.15	10.81	10.53	15.86	15.60	38.12
EV/EBIT Ratio	17.46	14.45	14.33	22.43	22.79	129.91
EV/FCF Ratio	-141.32	-	65.09	40.55	185.40	29.61
Debt / Equity Ratio	0.76	0.68	0.47	0.60	0.64	0.64
Debt / EBITDA Ratio	3.31	3.34	2.68	3.30	3.44	7.70
Debt / FCF Ratio	-	-	16.55	8.43	40.87	5.98
Asset Turnover	0.74	0.76	0.83	0.86	0.83	0.81
Inventory Turnover	2.65	2.77	3.06	3.39	3.54	3.47
Quick Ratio	0.66	0.55	0.47	0.68	0.72	0.99
Current Ratio	1.22	1.03	0.86	1.16	1.13	1.62
Return on Equity (ROE)	9.62%	2.45%	14.27%	5.44%	4.32%	3.63%
Return on Assets (ROA)	5.66%	4.84%	4.54%	4.03%	3.99%	0.81%
Return on Invested Capital (ROIC)	10.08%	4.38%	10.40%	9.50%	9.18%	1.82%
Return on Capital Employed (ROCE)	11.80%	10.50%	11.00%	8.80%	9.30%	1.60%
Earnings Yield	4.79%	1.70%	9.06%	2.41%	1.50%	0.72%
FCF Yield	-0.98%	-7.13%	1.98%	3.02%	0.67%	4.20%
Dividend Yield	0.35%	0.48%	-	-	-	-
Payout Ratio	8.66%	31.30%	5.98%	19.10%	26.35%	48.56%
Buyback Yield / Dilution	-0.01%	-0.71%	-3.21%	-0.59%	-3.21%	-3.31%
Total Shareholder Return	0.34%	-0.24%	-3.21%	-0.59%	-3.21%	-3.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.